News > Serum Institute's Covovax approved for kids aged 7 to 11 years

Serum Institute's Covovax approved for kids aged 7 to 11 years

The Drugs Controller General of India (DCGI) on Tuesday approved India's first indigenously developed mRNA vaccine against COVID-19 manufactured by Gennova Biopharmaceuticals for restricted emergency use for those aged 18 years and above, official sources said on Tuesday.

While other mRNA vaccines require to be stored at sub-zero temperatures, Gennova's mRNA vaccine can be stored at 2-8 degrees, an official source told PTI.